Applied DNA Sciences gains as it secures ~$3.6M proceeds from warrant exercise

Aug. 09, 2022 8:22 AM ETApplied DNA Sciences, Inc. (APDN)By: Preeti Singh, SA News Editor
  • Applied DNA Sciences (NASDAQ:APDN) shares rose 12% pre-market on Tuesday after the firm announced the receipt of ~$3.6M in net proceeds from warrant exercise by an institutional investor.
  • The Series B warrants exercised were issued in connection with a public offering that closed on August 8, 2022.
  • Each Series B warrant entitles its owner to purchase one share of common stock in the company at a per share price of $4.00 until Sep. 08, 2023; 2.1M Series B warrants associated with the offering remain outstanding.
  • Series A warrants were also issued in connection with the offering. All 3M Series A warrants remain outstanding until Aug. 09, 2027.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.